These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 34850060)
1. Tuning the lipophilic nature of pyclen-based 90Y3+ radiopharmaceuticals for β-radiotherapy. Le Fur M; Fougère O; Lepareur N; Rousseaux O; Tripier R; Beyler M Metallomics; 2021 Dec; 13(12):. PubMed ID: 34850060 [TBL] [Abstract][Full Text] [Related]
2. Pyclen Tri-n-butylphosphonate Ester as Potential Chelator for Targeted Radiotherapy: From Yttrium(III) Complexation to (90)Y Radiolabeling. Le Fur M; Beyler M; Lepareur N; Fougère O; Platas-Iglesias C; Rousseaux O; Tripier R Inorg Chem; 2016 Aug; 55(16):8003-12. PubMed ID: 27486673 [TBL] [Abstract][Full Text] [Related]
3. Expanding the Scope of Pyclen-Picolinate Lanthanide Chelates to Potential Theranostic Applications. Nizou G; Favaretto C; Borgna F; Grundler PV; Saffon-Merceron N; Platas-Iglesias C; Fougère O; Rousseaux O; van der Meulen NP; Müller C; Beyler M; Tripier R Inorg Chem; 2020 Aug; 59(16):11736-11748. PubMed ID: 32799456 [TBL] [Abstract][Full Text] [Related]
4. Stable and Inert Yttrium(III) Complexes with Pyclen-Based Ligands Bearing Pendant Picolinate Arms: Toward New Pharmaceuticals for β-Radiotherapy. Le Fur M; Beyler M; Molnár E; Fougère O; Esteban-Gómez D; Tircsó G; Platas-Iglesias C; Lepareur N; Rousseaux O; Tripier R Inorg Chem; 2018 Feb; 57(4):2051-2063. PubMed ID: 29400452 [TBL] [Abstract][Full Text] [Related]
5. 90Y-oxine-ethiodol, a potential radiopharmaceutical for the treatment of liver cancer. Yu J; Häfeli UO; Sands M; Dong Y Appl Radiat Isot; 2003 May; 58(5):567-73. PubMed ID: 12735973 [TBL] [Abstract][Full Text] [Related]
6. Combining a pyclen framework with conjugated antenna for the design of europium and samarium luminescent bioprobes. Hamon N; Galland M; Le Fur M; Roux A; Duperray A; Grichine A; Andraud C; Le Guennic B; Beyler M; Maury O; Tripier R Chem Commun (Camb); 2018 Jun; 54(48):6173-6176. PubMed ID: 29845153 [TBL] [Abstract][Full Text] [Related]
7. Reduction of skeletal accumulation of radioactivity by co-injection of DTPA in [90Y-DOTA0,Tyr3]octreotide solutions containing free 90Y3+. Breeman WA; De Jong MT; De Blois E; Bernard BF; De Jong M; Krenning EP Nucl Med Biol; 2004 Aug; 31(6):821-4. PubMed ID: 15246375 [TBL] [Abstract][Full Text] [Related]
8. Mixed-ligand complexes of yttrium-90 dialkyldithiocarbamates with 1,10-phenanthroline as a possible agent for therapy of hepatocellular carcinoma. Lopez A; Noiret N; Garin E; Lepareur N Appl Radiat Isot; 2014 Dec; 94():241-246. PubMed ID: 25238135 [TBL] [Abstract][Full Text] [Related]
9. Newer approaches to the radiolabeling of monoclonal antibodies by use of metal chelates. Gansow OA Int J Rad Appl Instrum B; 1991; 18(4):369-81. PubMed ID: 1864725 [TBL] [Abstract][Full Text] [Related]
10. 90Sr content in 90Y-labeled SIR-spheres and Zevalin. Metyko J; Erwin W; Poston J; Jimenez S Health Phys; 2014 Nov; 107(5 Suppl 3):S177-80. PubMed ID: 25272027 [TBL] [Abstract][Full Text] [Related]
11. A systematic comparative evaluation of 90Y-labeled bifunctional chelators for their use in targeted therapy. Chakravarty R; Chakraborty S; Dash A J Labelled Comp Radiopharm; 2014 Feb; 57(2):65-74. PubMed ID: 24678528 [TBL] [Abstract][Full Text] [Related]
12. Preparation and in vitro stability of (n,gamma) yttrium-90 hydroxyapatite. Khalid M; Mushtaq A Appl Radiat Isot; 2005 Apr; 62(4):587-90. PubMed ID: 15701413 [TBL] [Abstract][Full Text] [Related]
13. Yttrium-90-labeled human macroaggregated albumin for internal radiotherapy: combined use with DTPA. Watanabe N; Oriuchi N; Endo K; Inoue T; Tanada S; Murata H; Sasaki Y Nucl Med Biol; 1999 Oct; 26(7):847-51. PubMed ID: 10628567 [TBL] [Abstract][Full Text] [Related]
14. Complexation of Mn(II) by Rigid Pyclen Diacetates: Equilibrium, Kinetic, Relaxometric, Density Functional Theory, and Superoxide Dismutase Activity Studies. Garda Z; Molnár E; Hamon N; Barriada JL; Esteban-Gómez D; Váradi B; Nagy V; Pota K; Kálmán FK; Tóth I; Lihi N; Platas-Iglesias C; Tóth É; Tripier R; Tircsó G Inorg Chem; 2021 Jan; 60(2):1133-1148. PubMed ID: 33378171 [TBL] [Abstract][Full Text] [Related]
16. Radiolabeling morpholinos with 90Y, 111In, 188Re and 99mTc. Liu CB; Liu GZ; Liu N; Zhang YM; He J; Rusckowski M; Hnatowich DJ Nucl Med Biol; 2003 Feb; 30(2):207-14. PubMed ID: 12623121 [TBL] [Abstract][Full Text] [Related]
17. Preparation of a radionuclide/gel formulation for localised radiotherapy to a wide range of organs and tissues. Holte O; Skretting A; Tønnesen HH; Karlsen J Pharmazie; 2006 May; 61(5):420-4. PubMed ID: 16724539 [TBL] [Abstract][Full Text] [Related]
18. Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging? Walrand S; Flux GD; Konijnenberg MW; Valkema R; Krenning EP; Lhommel R; Pauwels S; Jamar F Eur J Nucl Med Mol Imaging; 2011 May; 38 Suppl 1():S57-68. PubMed ID: 21484382 [TBL] [Abstract][Full Text] [Related]
19. Ognjanović M; Radović M; Mirković M; Prijović Ž; Puerto Morales MD; Čeh M; Vranješ-Đurić S; Antić B ACS Appl Mater Interfaces; 2019 Nov; 11(44):41109-41117. PubMed ID: 31610125 [TBL] [Abstract][Full Text] [Related]
20. Large-scale purification of 90Sr from nuclear waste materials for production of 90Y, a therapeutic medical radioisotope. Wester DW; Steele RT; Rinehart DE; DesChane JR; Carson KJ; Rapko BM; Tenforde TS Appl Radiat Isot; 2003 Jul; 59(1):35-41. PubMed ID: 12878120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]